Cargando…

Genetic Variability of the Vitamin D Receptor Affects Susceptibility to Parkinson’s Disease and Dopaminergic Treatment Adverse Events

Vitamin D is a lipid-soluble molecule and an important transcriptional regulator in many tissues and organs, including the brain. Its role has been demonstrated also in Parkinson’s disease (PD) pathogenesis. Vitamin D receptor (VDR) is responsible for the initiation of vitamin D signaling cascade. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Redenšek, Sara, Kristanc, Tilen, Blagus, Tanja, Trošt, Maja, Dolžan, Vita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063754/ https://www.ncbi.nlm.nih.gov/pubmed/35517045 http://dx.doi.org/10.3389/fnagi.2022.853277

Ejemplares similares

Serotonin-Related Functional Genetic Variants Affect the Occurrence of Psychiatric and Motor Adverse Events of Dopaminergic Treatment in Parkinson’s Disease: A Retrospective Cohort Study
por: Redenšek, Sara, et al.
Publicado: (2022)

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson’s disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Clinical and Clinical-Pharmacogenetic Models for Prediction of the Most Common Psychiatric Complications Due to Dopaminergic Treatment in Parkinson’s Disease
por: Redenšek, Sara, et al.
Publicado: (2020)

Genetic Determinants of Parkinson's Disease: Can They Help to Stratify the Patients Based on the Underlying Molecular Defect?
por: Redenšek, Sara, et al.
Publicado: (2017)

Clinical-Pharmacogenetic Predictive Models for Time to Occurrence of Levodopa Related Motor Complications in Parkinson’s Disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Assessment of the Telomere Length and Its Effect on the Symptomatology of Parkinson’s Disease
por: Levstek, Tina, et al.
Publicado: (2021)

From Genomics to Omics Landscapes of Parkinson's Disease: Revealing the Molecular Mechanisms
por: Redenšek, Sara, et al.
Publicado: (2018)

Case report: application of pharmacogenetics in the personalized treatment of an elderly patient with a major depressive episode
por: Pjevac, Milica, et al.
Publicado: (2023)

Investigation of Paraoxonase-1 Genotype and Enzyme-Kinetic Parameters in the Context of Cognitive Impairment in Parkinson’s Disease
por: Petrič, Boštjan, et al.
Publicado: (2023)

Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies
por: Tsermpini, Evangelia Eirini, et al.
Publicado: (2022)

Inflammation and Oxidative Stress Gene Variability in Retinal Detachment Patients with and without Proliferative Vitreoretinopathy
por: Lumi, Xhevat, et al.
Publicado: (2023)

Association of Genetic Polymorphisms in Oxidative Stress and Inflammation Pathways with Glaucoma Risk and Phenotype
por: Atanasovska Velkovska, Makedonka, et al.
Publicado: (2021)

Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature
por: Redenšek Trampuž, Sara, et al.
Publicado: (2023)

Molecular Mechanisms Related to Responses to Oxidative Stress and Antioxidative Therapies in COVID-19: A Systematic Review
por: Tsermpini, Evangelia Eirini, et al.
Publicado: (2022)

Nanoscale Bilirubin Analysis in Translational Research and Precision Medicine by the Recombinant Protein HUG
por: Sist, Paola, et al.
Publicado: (2023)

Dopaminergic therapy affects learning and impulsivity in Parkinson’s disease
Publicado: (2014)

Dopaminergic therapy affects learning and impulsivity in Parkinson’s disease
por: Hiebert, Nole M, et al.
Publicado: (2014)

Genetic Variability of Antioxidative Mechanisms and Cardiotoxicity after Adjuvant Radiotherapy in HER2-Positive Breast Cancer Patients
por: Marinko, Tanja, et al.
Publicado: (2020)

Association of OPRM1, MIR23B, and MIR107 Genetic Variability with Acute Pain, Chronic Pain and Adverse Effects after Postoperative Tramadol and Paracetamol Treatment in Breast Cancer
por: Vidic, Zala, et al.
Publicado: (2023)

Genetic Variability in Molecular Pathways Implicated in Alzheimer's Disease: A Comprehensive Review
por: Vogrinc, David, et al.
Publicado: (2021)

Dopaminergic modulation of performance monitoring in Parkinson’s disease: An event-related potential study
por: Seer, Caroline, et al.
Publicado: (2017)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Genetic variability in sodium-glucose cotransporter 2 influences glycemic control and risk for diabetic retinopathy in type 2 diabetes patients
por: Klen, Jasna, et al.
Publicado: (2020)

Genetic Variability of Inflammation and Oxidative Stress Genes Affects Onset, Progression of the Disease and Survival of Patients with Amyotrophic Lateral Sclerosis
por: Ravnik-Glavač, Metka, et al.
Publicado: (2022)

Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson disease
por: Lee, Myung Jun, et al.
Publicado: (2021)

Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
por: Kojovic, Maja, et al.
Publicado: (2014)

The Influence of Genetic Variability of DNA Repair Mechanisms on the Risk of Malignant Mesothelioma
por: Levpuscek, Kristina, et al.
Publicado: (2019)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

Membrane phospholipid peroxidation promotes loss of dopaminergic neurons in psychological stress‐induced Parkinson's disease susceptibility
por: Lin, Xiao‐Min, et al.
Publicado: (2023)

Genetic polymorphisms in homologous recombination repair genes in healthy Slovenian population and their influence on DNA damage
por: Goricar, Katja, et al.
Publicado: (2012)

Genetic Variability in Antioxidative and Inflammatory Pathways Modifies the Risk for PCOS and Influences Metabolic Profile of the Syndrome
por: Herman, Rok, et al.
Publicado: (2020)

The Influence of Genetic Variability on the Risk of Developing Malignant Mesothelioma
por: Franko, Alenka, et al.
Publicado: (2018)

Evaluation of Soluble Mesothelin-related Peptides and MSLN Genetic Variability in Asbestos-related Diseases
por: Goricar, Katja, et al.
Publicado: (2020)

Systematic Search for Novel Circulating Biomarkers Associated with Extracellular Vesicles in Alzheimer’s Disease: Combining Literature Screening and Database Mining Approaches
por: Vogrinc, David, et al.
Publicado: (2021)

NBN, RAD51 and XRCC3 Polymorphisms as Potential Predictive Biomarkers of Adjuvant Radiotherapy Toxicity in Early HER2-Positive Breast Cancer
por: Goričar, Katja, et al.
Publicado: (2022)

Author Correction: Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson disease
por: Lee, Myung Jun, et al.
Publicado: (2022)

Learning from the past and expecting the future in Parkinsonism: Dopaminergic influence on predictions about the timing of future events
por: Tomassini, Alessandro, et al.
Publicado: (2019)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

Dopaminergic Dysregulation, Artistic Expressiveness, and Parkinson's Disease
por: López-Pousa, S., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_s7lhlpdj8b16h0ob8i9ohk5ic8